Back

Lifelong anticoagulation is the best option after unprovoked venous thromboembolism - CON

1 September 2019 (11:15 - 11:30)
Organised by:
Congress Presentation Part of: Controversies in the management of pulmonary hypertension and venous thromboembolism Treatment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Nicolas Meneveau

Regional University Hospital Jean Minjoz, Besancon (France)

5 More presentations in this session

Presentation thumbnail
Lifelong anticoagulation is the best option after unprovoked venous thromboembolism - PRO
Professor L. Mazzolai (Lausanne, CH)
Slides Video
Presentation thumbnail
Lifelong anticoagulation is the best option after unprovoked venous thromboembolism - Discussion
Video
Presentation thumbnail
Pulmonary hypertension due to left heart disease should be treated with drugs approved for idiopathic pulmonary arterial hypertension - PRO
Professor S. Rosenkranz (Cologne, DE)
Presentation thumbnail
Pulmonary hypertension due to left heart disease should be treated with drugs approved for idiopathic pulmonary arterial hypertension - CON
Doctor J. Bermejo Thomas (Madrid, ES)
Slides Video
Presentation thumbnail
Pulmonary hypertension due to left heart disease should be treated with drugs approved for idiopathic pulmonary arterial hypertension - Discussion
Video

Access the full session

Session thumbnail
Controversies in the management of pulmonary hypertension and venous thromboembolism

The Event

Event poster

ESC Congress 2019

1 September 2019 11:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources